Premium
Lyra Therapeutics Inc (LYRA)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0039 | -2.08556149733 | 0.187 | 0.199 | 0.1752 | 630519 | 0.18449304 | CS |
| 4 | -0.0265 | -12.643129771 | 0.2096 | 0.2286 | 0.1752 | 1248756 | 0.20088407 | CS |
| 12 | -0.0879 | -32.4354243542 | 0.271 | 0.28 | 0.1625 | 1921578 | 0.19614334 | CS |
| 26 | -0.1399 | -43.3126934985 | 0.323 | 0.344 | 0.1625 | 1401575 | 0.22985858 | CS |
| 52 | -4.6469 | -96.2091097308 | 4.83 | 6.79 | 0.1625 | 1789939 | 0.63743861 | CS |
| 156 | -3.4169 | -94.9138888889 | 3.6 | 8.18 | 0.1625 | 692824 | 1.15724206 | CS |
| 260 | -20.8169 | -99.1280952381 | 21 | 22 | 0.1625 | 470591 | 1.91143718 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
